Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection; Aspergillus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00001790
What this trial is testing

Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever and Neutropenia

Who this might be right for
FeverMycosesNeutropenia
National Cancer Institute (NCI) 120
Not applicableStudy completedNCT04172610
What this trial is testing

Prevalence of Influenza RelAted Invasive Aspergillosis

Who this might be right for
Invasive Pulmonary AspergillosisInfluenza, Human
Karolinska University Hospital 55
Not applicableActive Not RecruitingNCT06583512
What this trial is testing

Treatment Duration of IPA

Who this might be right for
Invasive AspergillosisAntifungal Therapy
Peking University People's Hospital 15
Early research (Phase 1)Study completedNCT02631954
What this trial is testing

Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers

Who this might be right for
Aspergillus InfectionsCandida InfectionsFungal Infections
Chong Kun Dang Pharmaceutical 24
Testing effectiveness (Phase 2)Study completedNCT00404092
What this trial is testing

Caspofungin Maximum Tolerated Dose in Patients With Invasive Aspergillosis

Who this might be right for
Invasive Aspergillosis
University of Cologne 46
Large-scale testing (Phase 3)Ended earlyNCT04876716
What this trial is testing

Azole-echinocandin Combination Therapy for Invasive Aspergillosis

Who this might be right for
Invasive Aspergillosis
Erasmus Medical Center 66
Not applicableStudy completedNCT01448226
What this trial is testing

Diagnosing Invasive Aspergillosis by Polymerase Chain Reaction (PCR) Based Investigation of Bronchoalveolar Lavage Samples During Antifungal Therapy

Who this might be right for
Invasive Aspergillosis
Heidelberg University 221
Testing effectiveness (Phase 2)Study completedNCT01383993
What this trial is testing

Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection

Who this might be right for
Aspergillosis, Aspergilloma
Pfizer 21
Not applicableStudy completedNCT03067350
What this trial is testing

Influence of a Combined Pharmacogenetic Score on Through Plasma Voriconazole Concentrations in Haematological Patients

Who this might be right for
Invasive AspergillosisHaematological Cancer PatientsVoriconazole
University Hospital, Grenoble 47
Not applicableStudy completedNCT05065658
What this trial is testing

Posaconazole Prophylaxis for CAPA Prevention in Critically-Ill Patients

Who this might be right for
COVID-19 Respiratory InfectionAspergillosis
Medical University of Graz 249
Testing effectiveness (Phase 2)Study completedNCT00059878
What this trial is testing

Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections

Who this might be right for
InfectionUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI)
Not applicableStudy completedNCT02106117
What this trial is testing

Exhaled Breath Analysis in the Early Detection of Aspergillosis

Who this might be right for
Invasive Aspergillosis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 120
Large-scale testing (Phase 3)Study completedNCT00001646
What this trial is testing

Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis

Who this might be right for
Acquired Immunodeficiency SyndromeAspergillosisHIV Infections+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableStudy completedNCT06564727
What this trial is testing

Uniportal VATS Resection for Pulmonary Aspergilloma : Evaluation of Prognostic Factors in a Single Center Experience

Who this might be right for
Pulmonary AspergillosisSurgery-ComplicationsThoracic Diseases
Hassan II University 51
Not applicableEnded earlyNCT01148160
What this trial is testing

Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy

Who this might be right for
Invasive Fungal Infection
Asan Medical Center 10
Not applicableNot Yet RecruitingNCT07152327
What this trial is testing

Terbinafine Hydrochloride for the Treatment of Otomycosis

Who this might be right for
OtomycosisFungal Ear Infection
Assiut University 50
Not applicableStudy completedNCT02569879
What this trial is testing

Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.

Who this might be right for
DiphtheriaAcellular PertussisTetanus+2 more
GlaxoSmithKline 1
Not applicableUnknownNCT05569824
What this trial is testing

LFD of Aspergillus Antigen in Paediatrics

Who this might be right for
Invasive Pulmonary AspergillosisInvasive Fungal Disease
St George's University Hospitals NHS Foundation Trust 20
Early research (Phase 1)Study completedNCT04267497
What this trial is testing

Nebulised Liposomal Amphotericin for Invasive Pulmonary Aspergillosis (NAIFI01 Study)

Who this might be right for
Invasive Pulmonary Aspergillosis
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 13
Not applicableStudy completedNCT00230243
What this trial is testing

Historical Control Study of Refractory IFI or Patients Intolerant to Standard Antifungal Therapy in Patients With Invasive Fungal Infections (Study P02387)

Who this might be right for
Infection, Invasive Fungal
Merck Sharp & Dohme LLC 330
Next Page